Innate Immune Responses

Vincent R. Racaniello

doi:10.1128/9781555816698.ch18

Chapter 18 : Innate Immune Responses

VIEW AFFILIATIONS HIDE AFFILIATIONS

Affiliations: 1: Department of Microbiology & Immunology, Columbia University College of Physicians and Surgeons, New York, NY 10032

Content Type: Monograph

Publication Year: 2010

Category: Viruses and Viral Pathogenesis

Book DOI: 10.1128/9781555816698

Chapter DOI: 10.1128/9781555816698.ch18

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:

Innate Immune Responses, Page 1 of 2

< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555816698/9781555816032_Chap18-1.gif /docserver/preview/fulltext/10.1128/9781555816698/9781555816032_Chap18-2.gif

Abstract:

When viruses enter the host, they are first detected by the innate immune system, which comprises cytokines, sentinel cells (dendritic cells [DCs] and macrophages), complement, and natural killer (NK) cells. A second family of pattern recognition receptors comprises the cytoplasmic sensors of viral nucleic acids, MDA-5 (melanoma differentiation associated gene-5), RIG-I (retinoic acid-inducible gene I), and LGP2. Interferon (IFN) production after infection of cultured cells with paramyxoviruses, VSV, influenza virus, and the flavivirus Japanese encephalitis virus is impaired in fibroblasts from rig-I -1- mice. RIG- I- like receptors (RLRs) play central roles in viral recognition and induction of antiviral innate responses in cDCs, macrophages, and fibroblasts. Infection of mda-5 -1- mice revealed that this protein is critical for detection of infection with picornaviruses, but not flaviviruses, influenza viruses, or paramyxoviruses. Mice lacking the nitric oxide synthase gene have reduced macrophage activation and β-cell apoptosis and consequently reduced virus-induced diabetes. Understanding viral countermeasures not only improves one's understanding of innate sensing pathways but may also suggest avenues for therapeutic intervention. Infection of cells with several picornaviruses leads to cleavage or degradation of MDA-5 and RIG-I. We survive only because we possess powerful intrinsic, innate, and adaptive immune defense systems. The study of how picornaviruses interact with the innate immune system is in its infancy. Understanding innate signaling pathways and how viruses counteract them should be a productive area of research for many years.

Citation: Racaniello V. 2010. Innate Immune Responses, p 287-302. In Ehrenfeld E, Domingo E, Roos R (ed), The Picornaviruses. ASM Press, Washington, DC. doi: 10.1128/9781555816698.ch18

Highlighted Text: Show | Hide

Full text loading...

Figures

Innate Immune Responses

[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555816698.ch18-1,webId=/content/author/10.1128/9781555816698.ch18-1,properties={foaf_givenname=Vincent R., foaf_name=Vincent R. Racaniello, foaf_surname=Racaniello, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555816698.ch18-aff1]]}]]

Citation: Racaniello V. 2010. Innate Immune Responses, p 287-302. In Ehrenfeld E, Domingo E, Roos R (ed), The Picornaviruses. ASM Press, Washington, DC. doi: 10.1128/9781555816698.ch18

/content/10.1128/9781555816698.ch18.ch18fig01

Figure 1.

Recognition of viral RNA by TLRs and RLRs in mammalian cells. TLR3 and TLR7/8 recognize dsRNA and ssRNA in the endosome, while RIG-I and MDA-5 recognize viral RNAs in the cytoplasm. The ligands for RIG-I are believed to be short dsRNAs or ssRNAs with a 5′-triphosphate. Different adaptor proteins transduce the signal from activated TLRs or RLRs through a pathway leading to activation of transcription proteins needed for synthesis of type I IFN and inflammatory cytokines. TRIF- and IPS-1-dependent pathways lead to activation of IRF3 and NF-κB, while MyD88-dependent pathways lead to activation of IRF7 and NF-κB.

10.1128/9781555816698/f0288-01_thmb.gif

10.1128/9781555816698/f0288-01.gif

Figure 1.

Citation: Racaniello V. 2010. Innate Immune Responses, p 287-302. In Ehrenfeld E, Domingo E, Roos R (ed), The Picornaviruses. ASM Press, Washington, DC. doi: 10.1128/9781555816698.ch18

/content/10.1128/9781555816698.ch18.ch18fig02

Figure 2.

Structure and activation of RLRs by RNA. RIG-I and MDA-5 reside in the cytoplasm in an inactive form in the absence of RNA. In this state, the sensor molecules are folded in a way that the CTD blocks the CARD (top). Viral RNAs (either dsRNA or ssRNA with 5′-phosphates) bind the CTD, leading to an ATP-dependent structural change that exposes the CARD. The CARD is available to interact with IPS-1, ultimately leading to transcription of IFN genes.

10.1128/9781555816698/f0289-01_thmb.gif

10.1128/9781555816698/f0289-01.gif

Figure 2.

Citation: Racaniello V. 2010. Innate Immune Responses, p 287-302. In Ehrenfeld E, Domingo E, Roos R (ed), The Picornaviruses. ASM Press, Washington, DC. doi: 10.1128/9781555816698.ch18

References

/content/book/10.1128/9781555816698.ch18

1. Autret, A.,, S. Martin-Latil,, C. Brisac,, L. Mousson,, F. Colbere-Garapin, and, B. Blondel. 2008. Early phosphatidylinositol 3-kinase/Akt pathway activation limits poliovirus-induced JNK-mediated cell death. J. Virol. 82: 3796– 3802.

2. Autret, A.,, S. Martin-Latil,, L. Mousson,, A. Wirotius,, F. Petit,, D. Arnoult,, F. Colbere-Garapin,, J. Estaquier, and, B. Blondel. 2007. Poliovirus induces Bax-dependent cell death mediated by c-Jun NH 2-terminal kinase. J. Virol. 81: 7504– 7516.

3. Balachandran, S., and, G. N. Barber. 2007. PKR in innate immunity, cancer, and viral oncolysis. Methods Mol. Biol. 383: 277– 301.

4. Barral, P. M.,, J. M. Morrison,, J. Drahos,, P. Gupta,, D. Sarkar,, P. B. Fisher, and, V. R. Racaniello. 2007. MDA-5 is cleaved in poliovirus-infected cells. J. Virol. 81: 3677– 3684.

5. Barral, P. M.,, D. Sarkar,, P. B. Fisher, and, V. R. Racaniello. 2009. RIG-I is cleaved during picornavirus infection. Virology 391: 171– 176.

6. Bartlett, N. W.,, R. P. Walton,, M. R. Edwards,, J. Aniscenko,, G. Caramori,, J. Zhu,, N. Glanville,, K. J. Choy,, P. Jourdan,, J. Burnet,, T. J. Tuthill,, M. S. Pedrick,, M. J. Hurle,, C. Plumpton,, N. A. Sharp,, J. N. Bussell,, D. M. Swallow,, J. Schwarze,, B. Guy,, J. W. Almond,, P. K. Jeffery,, C. M. Lloyd,, A. Papi,, R. A. Killington,, D. J. Rowlands,, E. D. Blair,, N. J. Clarke, and, S. L. Johnston. 2008. Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat. Med. 14: 199– 204.

7. Best, S. M. 2008. Viral subversion of apoptotic enzymes: escape from death row. Annu. Rev. Microbiol. 62: 171– 192.

8. Black, T. L.,, B. Safer,, A. Hovanessian, and, M. G. Katze. 1989. The cellular 68,000 -M r protein kinase is highly autophosphorylated and activated yet significantly degraded during poliovirus infection: implication for translational regulation. J. Virol. 63: 2244– 2251.

9. Bochkov, Y. A.,, K. M. Hanson,, S. Keles,, R. A. Brockman-Schneider,, N. N. Jarjour, and, J. E. Gern. 2010. Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma. Mucosal Immunol. 3: 69– 80.

10. Bodian, D. 1955. Emerging concept of poliomyelitis infection. Science 12: 105– 108.

11. Brabec-Zaruba, M.,, U. Berka,, D. Blaas, and, R. Fuchs. 2007. Induction of autophagy does not affect human rhinovirus type 2 production. J. Virol. 81: 10815– 10817.

12. Calandria, C.,, A. Irurzun,, A. Barco, and, L. Carrasco. 2004. Individual expression of poliovirus 2A pro and 3C pro induces activation of caspase-3 and PARP cleavage in HeLa cells. Virus Res. 104: 39– 49.

13. Campanella, M.,, A. S. de Jong,, K. W. Lanke,, W. J. Melchers,, P. H. Willems,, P. Pinton,, R. Rizzuto, and, F. J. van Kuppeveld. 2004. The coxsackievirus 2B protein suppresses apoptotic host cell responses by manipulating intracellular Ca 2+ homeostasis. J. Biol. Chem. 279: 18440– 18450.

14. Chau, D. H.,, J. Yuan,, H. Zhang,, P. Cheung,, T. Lim,, Z. Liu,, A. Sall, and, D. Yang. 2007. Coxsackievirus B3 proteases 2A and 3C induce apoptotic cell death through mitochondrial injury and cleavage of eIF4GI but not DAP5/p97/NAT1. Apoptosis 12: 513– 524.

15. Chen, Y.,, E. Hamati,, P. K. Lee,, W. M. Lee,, S. Wachi,, D. Schnurr,, S. Yagi,, G. Dolganov,, H. Boushey,, P. Avila, and, R. Wu. 2006. Rhinovirus induces airway epithelial gene expression through double-stranded RNA and IFN-dependent pathways. Am. J. Respir. Cell. Mol. Biol. 34: 192– 203.

16. Chin, K. C., and, P. Cresswell. 2001. Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc. Natl. Acad. Sci. USA 98: 15125– 15130.

17. Chinsangaram, J.,, M. Koster, and, M. J. Grubman. 2001. Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase. J. Virol. 75: 5498– 5503.

18. Choe, S. S.,, D. A. Dodd, and, K. Kirkegaard. 2005. Inhibition of cellular protein secretion by picornaviral 3A proteins. Virology 337: 18– 29.

19. Coccia, E. M.,, G. Romeo,, A. Nissim,, G. Marziali,, R. Albertini,, E. Affabris,, A. Battistini,, G. Fiorucci,, R. Orsatti,, G. B. Rossi, et al. 1990. A full-length murine 2-5A synthetase cDNA transfected in NIH-3T3 cells impairs EMCV but not VSV replication. Virology 179: 228– 233.

20. Coornaert, B.,, I. Carpentier, and, R. Beyaert. 2009. A20: central gatekeeper in inflammation and immunity. J. Biol. Chem. 284: 8217– 8221.

21. Cui, S.,, K. Eisenacher,, A. Kirchhofer,, K. Brzozka,, A. Lammens,, K. Lammens,, T. Fujita,, K. K. Conzelmann,, A. Krug, and, K. P. Hopfner. 2008. The C-terminal regulatory domain is the RNA 5′-triphosphate sensor of RIG-I. Mol. Cell 29: 169– 179.

22. de Los Santos, T.,, F. Diaz-San Segundo, and, M. J. Grubman. 2007. Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection. J. Virol. 81: 12803– 12815.

23. Doedens, J. R.,, T. H. Giddings, Jr., and, K. Kirkegaard. 1997. Inhibition of endoplasmic reticulum-to-Golgi traffic by polio-virus protein 3A: genetic and ultrastructural analysis. J. Virol. 71: 9054– 9064.

24. Drahos, J., and, V. R. Racaniello. 2009. Cleavage of IPS-1 in cells infected with human rhinovirus. J. Virol. 83: 11581– 11587.

25. Eldin, P.,, L. Papon,, A. Oteiza,, E. Brocchi,, T. G. Lawson, and, N. Mechti. 2009. TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus. J. Gen. Virol. 90: 536– 545.

26. Espert, L.,, G. Degols,, C. Gongora,, D. Blondel,, B. R. Williams,, R. H. Silverman, and, N. Mechti. 2003. ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses. J. Biol. Chem. 278: 16151– 16158.

27. Fahy, J. V.,, K. W. Kim,, J. Liu, and, H. A. Boushey. 1995. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J. Allergy Clin. Immunol. 95: 843– 852.

28. Fan, J.,, K. N. Son,, S. Y. Arslan,, Z. Liang, and, H. L. Lipton. 2009. Theiler’s murine encephalomyelitis virus leader protein is the only nonstructural protein tested that induces apoptosis when transfected into mammalian cells. J. Virol. 83: 6546– 6453.

29. Flodstrom, M.,, M. S. Horwitz,, A. Maday,, D. Balakrishna,, E. Rodriguez, and, N. Sarvetnick. 2001. A critical role for inducible nitric oxide synthase in host survival following coxsackievirus B4 infection. Virology 281: 205– 215.

30. Fraenkel, D. J.,, P. G. Bardin,, G. Sanderson,, F. Lampe,, S. L. Johnston, and, S. T. Holgate. 1995. Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am. J. Respir. Crit. Care Med. 151: 879– 886.

31. Freistadt, M. F.,, G. Kaplan, and, V. R. Racaniello. 1990. Heterogeneous expression of poliovirus receptor-related proteins in human cells and tissues. Mol. Cell. Biol. 10: 5700– 5706.

32. Frisancho-Kiss, S.,, S. E. Davis,, J. F. Nyland,, J. A. Frisancho,, D. Cihakova,, M. A. Barrett,, N. R. Rose, and, D. Fairweather. 2007. Cutting edge: cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease. J. Immunol. 178: 6710– 6714.

33. Garcia-Sastre, A.,, R. K. Durbin,, H. Zheng,, P. Palese,, R. Gertner,, D. E. Levy, and, J. E. Durbin. 1998. The role of interferon in influenza virus tissue tropism. J. Virol. 72: 8550– 8558.

34. Gitlin, L.,, W. Barchet,, S. Gilfillan,, M. Cella,, B. Beutler,, R. A. Flavell,, M. S. Diamond, and, M. Colonna. 2006. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. USA 103: 8459– 8464.

35. Hardarson, H. S.,, J. S. Baker,, Z. Yang,, E. Purevjav,, C. H. Huang,, L. Alexopoulou,, N. Li,, R. A. Flavell,, N. E. Bowles, and, J. G. Vallejo. 2007. Toll-like receptor 3 is an essential component of the innate stress response in virus-induced cardiac injury. Am. J. Physiol. Heart Circ. Physiol. 292: H251– H258.

36. Hassel, B. A.,, A. Zhou,, C. Sotomayor,, A. Maran, and, R. H. Silverman. 1993. A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J. 12: 3297– 3304.

37. Hato, S. V.,, C. Ricour,, B. M. Schulte,, K. H. Lanke,, M. de Bruijni,, J. Zoll,, W. J. Melchers,, T. Michiels, and, F. J. van Kuppeveld. 2007. The mengovirus leader protein blocks interferon-alpha/beta gene transcription and inhibits activation of interferon regulatory factor 3. Cell. Microbiol. 9: 2921– 2930.

38. Hewson, C. A.,, A. Jardine,, M. R. Edwards,, V. Laza-Stanca, and, S. L. Johnston. 2005. Toll-like receptor 3 is induced by and mediates antiviral activity against rhinovirus infection of human bronchial epithelial cells. J. Virol. 79: 12273– 12279.

39. Hiscott, J. 2007. Convergence of the NF-κB and IRF pathways in the regulation of the innate antiviral response. Cytokine Growth Factor Rev. 18: 483– 490.

40. Holland, J. J. 1961. Receptor affinities as major determinants of enterovirus tissue tropisms in humans. Virology 15: 312– 326.

41. Honda, K.,, H. Yanai,, H. Negishi,, M. Asagiri,, M. Sato,, T. Mizutani,, N. Shimada,, Y. Ohba,, A. Takaoka,, N. Yoshida, and, T. Taniguchi. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772– 777.

42. Hornung, V.,, J. Ellegast,, S. Kim,, K. Brzozka,, A. Jung,, H. Kato,, H. Poeck,, S. Akira,, K. K. Conzelmann,, M. Schlee,, S. Endres, and, G. Hartmann. 2006. 5′-triphosphate RNA is the ligand for RIG-I. Science 314: 994– 997.

43. Huang, S. C.,, C. L. Chang,, P. S. Wang,, Y. Tsai, and, H. S. Liu. 2009. Enterovirus 71-induced autophagy detected in vitro and in vivo promotes viral replication. J. Med. Virol. 81: 1241– 1252.

44. Ida-Hosonuma, M.,, T. Iwasaki,, T. Yoshikawa,, N. Nagata,, Y. Sato,, T. Sata,, M. Yoneyama,, T. Fujita,, C. Taya,, H. Yonekawa, and, S. Koike. 2005. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J. Virol. 79: 4460– 4469.

45. Jackson, W. T.,, T. H. Giddings, Jr.,, M. P. Taylor,, S. Mulinyawe,, M. Rabinovitch,, R. R. Kopito, and, K. Kirkegaard. 2005. Subversion of cellular autophagosomal machinery by RNA viruses. PLoS Biol. 3: e156.

46. Johnston, S. L.,, P. K. Pattemore,, G. Sanderson,, S. Smith,, M. J. Campbell,, L. K. Josephs,, A. Cunningham,, B. S. Robinson,, S. H. Myint,, M. E. Ward,, D. A. Tyrrell, and, S. T. Holgate. 1996. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am. J. Respir. Crit. Care Med. 154: 654– 660.

47. Kang, D. C.,, R. V. Gopalkrishnan,, Q. Wu,, E. Jankowsky,, A. M. Pyle, and, P. B. Fisher. 2002. mda-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc. Natl. Acad. Sci. USA 99: 637– 642.

48. Kato, H.,, S. Sato,, M. Yoneyama,, M. Yamamoto,, S. Uematsu,, K. Matsui,, T. Tsujimura,, K. Takeda,, T. Fujita,, O. Takeuchi, and, S. Akira. 2005. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23: 19– 28.

49. Kato, H.,, O. Takeuchi,, E. Mikamo-Satoh,, R. Hirai,, T. Kawai,, K. Matsushita,, A. Hiiragi,, T. S. Dermody,, T. Fujita, and, S. Akira. 2008. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J. Exp. Med. 205: 1601– 1610.

50. Kato, H.,, O. Takeuchi,, S. Sato,, M. Yoneyama,, M. Yamamoto,, K. Matsui,, S. Uematsu,, A. Jung,, T. Kawai,, K. J. Ishii,, O. Yamaguchi,, K. Otsu,, T. Tsujimura,, C. S. Koh,, C. Reis e Sousa,, Y. Matsuura,, T. Fujita, and, S. Akira. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101– 105.

51. Kawai, T., and, S. Akira. 2008. Toll-like receptor and RIG-I-like receptor signaling. Ann. N. Y. Acad. Sci. 1143: 1– 20.

52. Kawai, T.,, K. Takahashi,, S. Sato,, C. Coban,, H. Kumar,, H. Kato,, K. J. Ishii,, O. Takeuchi, and, S. Akira. 2005. IPS-1, an adaptor triggering RIG-I - and Mda5-mediated type I inter-feron induction. Nat. Immunol. 6: 981– 988.

53. Khetsuriani, N.,, N. N. Kazerouni,, D. D. Erdman,, X. Lu,, S. C. Redd,, L. J. Anderson, and, W. G. Teague. 2007. Prevalence of viral respiratory tract infections in children with asthma. J. Allergy Clin. Immunol. 119: 314– 321.

54. Kirkegaard, K.,, M. P. Taylor, and, W. T. Jackson. 2004. Cellular autophagy: surrender, avoidance and subversion by microorganisms. Nat. Rev. Microbiol. 2: 301– 314.

55. Koike, S.,, H. Horie,, I. Dise,, H. Okitsu,, M. Yoshida,, N. Iizuka,, K. Takeuthi,, T. Takegami, and, A. Nomoto. 1990. The polio-virus receptor protein is produced both as membrane-bound and secreted forms. EMBO J. 9: 3217– 3224.

56. Koike, S.,, C. Taya,, J. Aoki,, Y. Matsuda,, I. Ise,, H. Takeda,, T. Matsuzaki,, H. Amanuma,, H. Yonekawa, and, A. Nomoto. 1994. Characterization of three different transgenic mouse lines that carry human poliovirus receptor gene: influence of the transgene expression on pathogenesis. Arch. Virol. 139: 351– 363.

57. Komuro, A., and, C. M. Horvath. 2006. RNA- and virus-independent inhibition of antiviral signaling by RNA helicase LGP2. J. Virol. 80: 12332– 12242.

58. Kotla, S.,, T. Peng,, R. E. Bumgarner, and, K. E. Gustin. 2008. Attenuation of the type I interferon response in cells infected with human rhinovirus. Virology 374: 399– 410.

59. Kovacsovics, M.,, F. Martinon,, O. Micheau,, J. L. Bodmer,, K. Hofmann, and, J. Tschopp. 2002. Overexpression of Helicard, a CARD-containing helicase cleaved during apoptosis, accelerates DNA degradation. Curr. Biol. 12: 838– 843.

60. Kulka, M.,, M. S. Calvo,, D. T. Ngo,, S. Q. Wales, and, B. B. Goswami. 2009. Activation of the 2-5OAS/RNase L pathway in CVB1 or HAV/18f infected FRhK-4 cells does not require induction of OAS1 or OAS2 expression. Virology 388: 169– 184.

61. Kumar, H.,, T. Kawai,, H. Kato,, S. Sato,, K. Takahashi,, C. Coban,, M. Yamamoto,, S. Uematsu,, K. J. Ishii,, O. Takeuchi, and, S. Akira. 2006. Essential role of IPS-1 in innate immune responses against RNA viruses. J. Exp. Med. 203: 1795– 1803.

62. Kuss, S. K.,, C. A. Etheredge, and, J. K. Pfeiffer. 2008. Multiple host barriers restrict poliovirus trafficking in mice. PLoS Pathog. 4: e1000082.

63. Lee, K. K.,, R. G. Hegele,, J. Manfreda,, K. Wooldrage,, A. B. Becker,, A. C. Ferguson,, H. Dimich-Ward,, W. T. Watson, and, M. Chan-Yeung. 2007. Relationship of early childhood viral exposures to respiratory symptoms, onset of possible asthma and atopy in high risk children: the Canadian Asthma Primary Prevention Study. Pediatr. Pulmonol. 42: 290– 297.

64. Lee, Y. S.,, N. Li,, S. Shin, and, H. S. Jun. 2009. Role of nitric oxide in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J. Virol. 83: 8004– 8011.

65. Lemanske, R. F., Jr.,, D. J. Jackson,, R. E. Gangnon,, M. D. Evans,, Z. Li,, P. A. Shult,, C. J. Kirk,, E. Reisdorf,, K. A. Roberg,, E. L. Anderson,, K. T. Carlson-Dakes,, K. J. Adler,, S. Gilbertson-White,, T. E. Pappas,, D. F. Dasilva,, C. J. Tisler, and, J. E. Gern. 2005. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J. Allergy Clin. Immunol. 116: 571– 577.

66. Li, X. D.,, L. Sun,, R. B. Seth,, G. Pineda, and, Z. J. Chen. 2005. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc. Natl. Acad. Sci. USA 102: 17717– 17722.

67. Li, X. L.,, J. A. Blackford, and, B. A. Hassel. 1998. RNase L mediates the antiviral effect of interferon through a selective reduction in viral RNA during encephalomyocarditis virus infection. J. Virol. 72: 2752– 2759.

68. Liu, L.,, I. Botos,, Y. Wang,, J. N. Leonard,, J. Shiloach,, D. M. Segal, and, D. R. Davies. 2008. Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science 320: 379– 381.

69. Malathi, K.,, B. Dong,, M. Gale, Jr., and, R. H. Silverman. 2007. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448: 816– 819.

70. Mendelsohn, C.,, E. Wimmer, and, V. R. Racaniello. 1989. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence and expression of a new member of the immunoglobulin superfamily. Cell 56: 855– 865.

71. Meylan, E.,, J. Curran,, K. Hofmann,, D. Moradpour,, M. Binder,, R. Bartenschlager, and, J. Tschopp. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437: 1167– 1172.

72. Morrison, J. M., and, V. R. Racaniello. 2009. Proteinase 2A pro is essential for enterovirus replication in type I interferon-treated cells. J. Virol. 83: 4412– 4422.

73. Negishi, H.,, T. Osawa,, K. Ogami,, X. Ouyang,, S. Sakaguchi,, R. Koshiba,, H. Yanai,, Y. Seko,, H. Shitara,, K. Bishop,, H. Yonekawa,, T. Tamura,, T. Kaisho,, C. Taya,, T. Taniguchi, and, K. Honda. 2008. A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity. Proc. Natl. Acad. Sci. USA 105: 20446– 20451.

74. Neznanov, N.,, K. M. Chumakov,, L. Neznanova,, A. Almasan,, A. K. Banerjee, and, A. V. Gudkov. 2005. Proteolytic cleavage of the p65-RelA subunit of NF-κB during poliovirus infection. J. Biol. Chem. 280: 24153– 24158.

75. Nusslein-Volhard, C., and, E. Wieschaus. 1980. Mutations affecting segment number and polarity in Drosophila. Nature 287: 795– 801.

76. Ohka, S.,, H. Igarashi,, N. Nagata,, M. Sakai,, S. Koike,, T. Nochi,, H. Kiyono, and, A. Nomoto. 2007. Establishment of a poliovirus oral infection system in human poliovirus receptor-expressing transgenic mice that are deficient in alpha/beta interferon receptor. J. Virol. 81: 7902– 7912.

77. Pacifico, L.,, M. Iacobini,, F. Viola,, B. Werner,, G. Mancuso, and, C. Chiesa. 2000. Chemokine concentrations in nasal washings of infants with rhinovirus illnesses. Clin. Infect. Dis. 31: 834– 838.

78. Papadopoulos, N. G.,, A. Papi,, J. Meyer,, L. A. Stanciu,, S. Salvi,, S. T. Holgate, and, S. L. Johnston. 2001. Rhinovirus infection up-regulates eotaxin and eotaxin-2 expression in bronchial epithelial cells. Clin. Exp. Allergy 31: 1060– 1066.

79. Papon, L.,, A. Oteiza,, T. Imaizumi,, H. Kato,, E. Brocchi,, T. G. Lawson,, S. Akira, and, N. Mechti. 2009. The viral RNA recognition sensor RIG-I is degraded during encephalomyocarditis virus (EMCV) infection. Virology 393: 311– 318.

80. Pfeiffer, J. K., and, K. Kirkegaard. 2006. Bottleneck-mediated quasispecies restriction during spread of an RNA virus from inoculation site to brain. Proc. Natl. Acad. Sci. USA 103: 5520– 5525.

81. Pichlmair, A.,, O. Schulz,, C. P. Tan,, T. I. Naslund,, P. Liljestrom,, F. Weber, and, C. Reis e Sousa. 2006. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314: 997– 1001.

82. Plumet, S.,, F. Herschke,, J. M. Bourhis,, H. Valentin,, S. Longhi, and, D. Gerlier. 2007. Cytosolic 5′-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response. PLoS One 2: e279.

83. Proud, D.,, R. B. Turner,, B. Winther,, S. Wiehler,, J. P. Tiesman,, T. D. Reichling,, K. D. Juhlin,, A. W. Fulmer,, B. Y. Ho,, A. A. Walanski,, C. L. Poore,, H. Mizoguchi,, L. Jump,, M. L. Moore,, C. K. Zukowski, and, J. W. Clymer. 2008. Gene expression profiles during in vivo human rhinovirus infection: insights into the host response. Am. J. Respir. Crit. Care Med. 178: 962– 968.

84. Randall, R. E., and, S. Goodbourn. 2008. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89: 1– 47.

85. Rebsamen, M.,, E. Meylan,, J. Curran, and, J. Tschopp. 2008. The antiviral adaptor proteins Cardif and Trif are processed and inactivated by caspases. Cell Death Differ. 15: 1804– 1811.

86. Ren, R., and, V. Racaniello. 1992. Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice. J. Virol. 66: 296– 304.

87. Ricour, C.,, S. Delhaye,, S. V. Hato,, T. D. Olenyik,, B. Michel,, F. J. van Kuppeveld,, K. E. Gustin, and, T. Michiels. 2009. Inhibition of mRNA export and dimerization of interferon regulatory factor 3 by Theiler’s virus leader protein. J. Gen. Virol. 90: 177– 186.

88. Romanova, L. I.,, P. V. Lidsky,, M. S. Kolesnikova,, K. V. Fominykh,, A. P. Gmyl,, E. V. Sheval,, S. V. Hato,, F. J. van Kuppeveld, and, V. I. Agol. 2009. Antiapoptotic activity of the cardiovirus leader protein, a viral “security” protein. J. Virol. 83: 7273– 7284.

89. Rothenfusser, S.,, N. Goutagny,, G. DiPerna,, M. Gong,, B. G. Monks,, A. Schoenemeyer,, M. Yamamoto,, S. Akira, and, K. A. Fitzgerald. 2005. The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J. Immunol. 175: 5260– 5268.

90. Ryman, K. D.,, W. B. Klimstra,, K. B. Nguyen,, C. A. Biron, and, R. E. Johnston. 2000. Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism. J. Virol. 74: 3366– 3378.

91. Sabbah, A.,, T. H. Chang,, R. Harnack,, V. Frohlich,, K. Tominaga,, P. H. Dube,, Y. Xiang, and, S. Bose. 2009. Activation of innate immune antiviral responses by Nod2. Nat. Immunol. 10: 1073– 1080.

92. Sabin, A. B. 1956. Pathogenesis of poliomyelitis: reappraisal in light of new data. Science 123: 1151– 1157.

93. Saito, T.,, R. Hirai,, Y. M. Loo,, D. Owen,, C. L. Johnson,, S. C. Sinha,, S. Akira,, T. Fujita, and, M. Gale, Jr. 2007. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc. Natl. Acad. Sci. USA 104: 582– 587.

94. Saito, T.,, D. M. Owen,, F. Jiang,, J. Marcotrigiano, and, M. Gale, Jr. 2008. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454: 523– 527.

95. Saitoh, S., and, K. Miyake. 2009. Regulatory molecules required for nucleotide-sensing Toll-like receptors. Immunol. Rev. 227: 32– 43.

96. Salako, M. A.,, M. J. Carter, and, G. E. Kass. 2006. Coxsackievirus protein 2BC blocks host cell apoptosis by inhibiting caspase-3. J. Biol. Chem. 281: 16296– 16304.

97. Schroth, M. K.,, E. Grimm,, P. Frindt,, D. M. Galagan,, S. I. Konno,, R. Love, and, J. E. Gern. 1999. Rhinovirus replication causes RANTES production in primary bronchial epithelial cells. Am. J. Respir. Cell. Mol. Biol. 20: 1220– 1228.

98. Schuster, A.,, J. V. Fahy,, I. Ueki, and, J. A. Nadel. 1995. Cystic fibrosis sputum induces a secretory response from airway gland serous cells that can be prevented by neutrophil protease inhibitors. Eur. Respir. J. 8: 10– 14.

99. Seth, R. B.,, L. Sun,, C. K. Ea, and, Z. J. Chen. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF 3. Cell 122: 669– 682.

100. Silverman, R. H. 2007. Viral encounters with 2′, 5′-oligoadenylate synthetase and RNase L during the interferon antiviral response. J. Virol. 81: 12720– 12729.

101. So, E. Y., and, B. S. Kim. 2009. Theiler’s virus infection induces TLR3-dependent upregulation of TLR2 critical for proinflammatory cytokine production. Glia 57: 1216– 1226.

102. Sun, Q.,, L. Sun,, H. H. Liu,, X. Chen,, R. B. Seth,, J. Forman, and, Z. J. Chen. 2006. The specific and essential role of MAVS in antiviral innate immune responses. Immunity 24: 633– 642.

103. Takahasi, K.,, M. Yoneyama,, T. Nishihori,, R. Hirai,, H. Ku-meta,, R. Narita,, M. Gale, Jr.,, F. Inagaki, and, T. Fujita. 2008. Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol. Cell 29: 428– 440.

104. Takeuchi, O., and, S. Akira. 2008. MDA5/RIG-I and virus recognition. Curr. Opin. Immunol. 20: 17– 22.

105. Taylor, M. P., and, K. Kirkegaard. 2008. Potential subversion of autophagosomal pathway by picornaviruses. Autophagy 4: 286– 289.

106. Terajima, M.,, M. Yamaya,, K. Sekizawa,, S. Okinaga,, T. Suzuki,, N. Yamada,, K. Nakayama,, T. Ohrui,, T. Oshima,, Y. Numazaki, and, H. Sasaki. 1997. Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1β. Am. J. Physiol. 273: L749– L759.

107. Townsend, H. L.,, B. K. Jha,, J. Q. Han,, N. K. Maluf,, R. H. Silverman, and, D. J. Barton. 2008. A viral RNA competitively inhibits the antiviral endoribonuclease domain of RNase L. RNA 14: 1026– 1036.

108. Townsend, H. L.,, B. K. Jha,, R. H. Silverman, and, D. J. Barton. 2008. A putative loop E motif and an H-H kissing loop interaction are conserved and functional features in a group C enterovirus RNA that inhibits ribonuclease L. RNA Biol. 5: 263– 272.

109. Venkataraman, T.,, M. Valdes,, R. Elsby,, S. Kakuta,, G. Caceres,, S. Saijo,, Y. Iwakura, and, G. N. Barber. 2007. Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J. Immunol. 178: 6444– 6455.

110. Wang, X.,, E. R. Hinson, and, P. Cresswell. 2007. The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe 2: 96– 105.

111. Wark, P. A., and, P. G. Gibson. 2006. Asthma exacerbations. 3: pathogenesis. Thorax 61: 909– 915.

112. Wessels, E.,, D. Duijsings,, K. H. Lanke,, S. H. van Dooren,, C. L. Jackson,, W. J. Melchers, and, F. J. van Kuppeveld. 2006. Effects of picornavirus 3A proteins on protein transport and GBF1-dependent COP-I recruitment. J. Virol. 80: 11852– 11860.

113. Wessely, R.,, K. Klingel,, K. U. Knowlton, and, R. Kandolf. 2001. Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication. Circulation 103: 756– 761.

114. Whitton, J. L.,, C. T. Cornell, and, R. Feuer. 2005. Host and virus determinants of picornavirus pathogenesis and tropism. Nat. Rev. Microbiol. 3: 765– 776.

115. Wong, J.,, J. Zhang,, X. Si,, G. Gao,, I. Mao,, B. M. McManus, and, H. Luo. 2008. Autophagosome supports coxsackievirus B3 replication in host cells. J. Virol. 82: 9143– 9153.

116. Xu, L. G.,, Y. Y. Wang,, K. J. Han,, L. Y. Li,, Z. Zhai, and, H. B. Shu. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19: 727– 740.

117. Yang, Y.,, Y. Liang,, L. Qu,, Z. Chen,, M. Yi,, K. Li, and, S. M. Lemon. 2007. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc. Natl. Acad. Sci. USA 104: 7253– 7258.

118. Yang, Y. L.,, L. F. Reis,, J. Pavlovic,, A. Aguzzi,, R. Schafer,, A. Kumar,, B. R. Williams,, M. Aguet, and, C. Weissmann. 1995. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J. 14: 6095– 6106.

119. Yoneyama, M., and, T. Fujita. 2008. Structural mechanism of RNA recognition by the RIG-I-like receptors. Immunity 29: 178– 181.

120. Yoneyama, M.,, M. Kikuchi,, K. Matsumoto,, T. Imaizumi,, M. Miyagishi,, K. Taira,, E. Foy,, Y. M. Loo,, M. Gale, Jr.,, S. Akira,, S. Yonehara,, A. Kato, and, T. Fujita. 2005. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 175: 2851– 2858.

121. Yoneyama, M.,, M. Kikuchi,, T. Natsukawa,, N. Shinobu,, T. Imaizumi,, M. Miyagishi,, K. Taira,, S. Akira, and, T. Fujita. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5: 730– 737.

122. Yoshikawa, T.,, T. Iwasaki,, M. Ida-Hosonuma,, M. Yoneyama,, T. Fujita,, H. Horie,, M. Miyazawa,, S. Abe,, B. Simizu, and, S. Koike. 2006. Role of the alpha/beta interferon response in the acquisition of susceptibility to poliovirus by kidney cells in culture. J. Virol. 80: 4313– 4325.

123. Zaragoza, C.,, C. J. Ocampo,, M. Saura,, C. Bao,, M. Leppo,, A. Lafond-Walker,, D. R. Thiemann,, R. Hruban, and, C. J. Lowenstein. 1999. Inducible nitric oxide synthase protection against coxsackievirus pancreatitis. J. Immunol. 163: 5497– 5504.

124. Zaragoza, C.,, M. Saura,, E. Y. Padalko,, E. Lopez-Rivera,, T. R. Lizarbe,, S. Lamas, and, C. J. Lowenstein. 2006. Viral protease cleavage of inhibitor of κBα triggers host cell apoptosis. Proc. Natl. Acad. Sci. USA 103: 19051– 19056.

125. Zhou, A.,, J. Paranjape,, T. L. Brown,, H. Nie,, S. Naik,, B. Dong,, A. Chang,, B. Trapp,, R. Fairchild,, C. Colmenares, and, R. H. Silverman. 1997. Interferon action and apoptosis are defective in mice devoid of 2′, 5′-oligoadenylate-dependent RNase L. EMBO J. 16: 6355– 6363.

126. Zhou, A.,, J. M. Paranjape,, S. D. Der,, B. R. Williams, and, R. H. Silverman. 1999. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. Virology 258: 435– 440.

127. Zhu, Z.,, W. Tang,, J. M. Gwaltney, Jr.,, Y. Wu, and, J. A. Elias. 1997. Rhinovirus stimulation of interleukin-8 in vivo and in vitro: role of NF-κB. Am. J. Physiol. 273: L814– L824.